Of the Field

13th Annual Immuno-Oncology Summit

Join us at the Immuno-Oncology Summit where we convene to advance our understanding of the immune system, propelling the development of next-generation immunotherapies to optimize patient treatment outcomes.

Visit the official site
10Speakers
4Sponsors
0On the bill · sessions
14Companies · in total
§I

Speakers

Programmed at 13th, in alphabetical order.
Biao Zheng, PhD
CEO · BRL Medicine
Carter Caldwell, MBA
Co-Investment Program Director · University of Pennsylvania
David Sommerhalder, MD
Clinical Investigator, Oncology · NEXT Oncology
Karen Chagin, MD
Senior Vice President, Early Stage Development · Adaptimmune
Kristen Meerbrey, PhD
Director of Target Discovery, Therapeutic Innovation Center · Baylor College of Medicine
Margery Ma, PhD
Principal Consultant, NonClinical Regulatory Affairs · Eliquent Life Sciences
Rakesh Dixit, PhD, DABT
President & Founder · Bionavigen Oncology, LLC and Regio Biosciences
Shameer Khader, PhD
Executive Director, Global Head of Data Science, Data Engineering and Computational Biology · Sanofi
Tatiana Novobrantseva, PhD
CSO · NextPoint Therapeutics
Vitalay Fomin, PhD
Co-Founder · Numenos AI
§II

Sponsors

The houses behind the program. Tiers as disclosed.
IRBM
Mispro
Nona Biosciences
Wuxi App Tec